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Autism spectrum disorders (ASD) are highly heterogeneous pediatric developmental disorders with estimated heritability more 
than 70%. Although the genetic factors in ASD are mainly unknown, a large number of gene mutations have been found, espe-
cially in genes involved in neurogenesis. The Neurexin-Neuroligin-Shank (NRXN-NLGN-SHANK) pathway plays a key role 
in the formation, maturation and maintenance of synapses, consistent with the hypothesis of neurodevelopmental abnormality 
in ASD. Presynaptic NRXNs interact with postsynaptic NLGNs in excitatory glutamatergic synapses. SHANK proteins func-
tion as core components of the postsynaptic density (PSD) by interacting with multiple proteins. Recently, deletions and point 
mutations of the SHANK1 gene have been detected in ASD individuals, indicating the involvement of SHANK1 in ASD. This 
review focuses on the function of SHANK1 protein, Shank1 mouse models, and the molecular genetics of the SHANK1 gene in 
human ASD. 
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Autism spectrum disorder (ASD) is a complex neurodevel-
opmental disease characterized by impaired social interac-
tion and language development and repetitive and stereo- 
typed behaviors and interests. ASD is more frequent in  
males than females, with an approximate ratio of 4:1 [1].  
Twin and family studies indicate that genetic factors play an 
important role in the etiology of autism with the heritability 
estimate more than 90% [2,3]. Though the causes of ASD 
are largely unknown, neurexin-neuroligin-shank (NRXN- 
NLGN-SHANK) pathway genes mutations have been  
implicated in ASD [4–20]. NLGN proteins, expressed 
highly in the brain, are postsynaptic adhesion molecules 
interacting with presynaptic NRXNs [9]. SHANK proteins 
function as core components of the postsynaptic density 
(PSD) by interacting with multiple proteins [21]. The im-
pact of this pathway on synaptic function provides an im-
portant perspective for understanding the pathogenesis of 
ASD. The SHANK family has three members: SHANK1, 
SHANK2 and SHANK3. All SHANK family members are 
expressed in the brain and are present at PSD of excitatory 
synapses. SHANK3 was the first and one of the best charac-
terized genes implicated in ASD in SHANK family [19,20]. 
Recently, deletions and point mutations of the SHANK1 
gene have been detected in ASD individuals, indicating the 
involvement of SHANK1 in ASD [22]. This review focuses 
on the function of SHANK1 protein, Shank1 mouse models, 
and the molecular genetics of the SHANK1 gene in human 
ASD. 
1  The structure and function of SHANK1  
protein 
All three SHANK proteins have similar sets of domains: 
N-terminal multiple ankyrin repeats, a Src homology 3 
(SH3) domain, a PSD-95/Discs large/ZO-1 (PDZ) domain, 
a long proline-rich region containing homer- and cortac-
tin-binding sites, and a sterile alpha motif (SAM) domain. 
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Through these multiple domains, SHANK family proteins 
interact with more than 30 synaptic proteins, consistent with 
the function of scaffolding proteins [23].  
The major reported directly interacting proteins with 
SHANKs are GKAP (guanylate kinase-associated protein), 
GRIP (glutamate receptor-interacting protein), Homer and 
Cortactin. GKAP binds to the SHANK PDZ domain by C 
terminus sequence QTRL and interacts with NMDA 
(N-methyld-aspartate) receptor by PSD-95 protein [24,25]. 
GRIP protein interacts with SHANK by SH3 domain and 
also with membrane receptor AMPAR (AMPA-type gluta-
mate receptor) [26,27]. There is a proline-serine-rich seg-
ment of more than 1,000 residues between PDZ domain and 
SAM domain, which mediates multiple sets of protein in-
teractions by binding with SH3, EVH1 (enabled/ 
vasodilator-stimulated phosphoprotein homology 1) and 
WW domains. Homer protein family includes one EVH1 
domain, interacting with SHANKs by PPXXF sequence 
[28,29]. Homer mediates release of intracellular calcium in 
response to receptor stimulation by binding with mGluRs 
(metabotropic glutamate receptors) and IP3 (inositol 
1,4,5-trisphosphate) receptors. Cortactin is an F-actin- 
binding protein, recognizing KPPVPPKP sequence of pro-
line-rich region of SHANKs by its SH3 domain. Cortactin is 
rich in contact sites of cell-matrix, lamellipodia of cultured 
cells and growth cones of neurons, mediating the organiza-
tion of the actin cytoskeleton in the cell cortex and in den-
dritic spines [30,31]. Thus, SHANK has the potential to 
interact indirectly with three major classes of postsynaptic 
glutamate receptor via their interacting proteins: NMDA 
receptors via the PSD-95/GKAP complex, mGluRs via 
Homer, and AMPA receptors via GRIP. The C-terminal 
SAM domain is a region critical for the postsynaptic locali-
zation of SHANK2 and SHANK3 while SHANK1 utilizes 
its PDZ domain for its synaptic localization [32–34]. 
In rats, SHANK2 and SHANK3 are expressed widely in 
many tissues such as the brain, kidney, heart, liver and 
spleen while SHANK1 mRNA and protein are expressed 
almost exclusively in the brain [35,36]. In cultured devel-
oping neurons, SHANK is highly expressed in growth cones 
and accumulates at synaptic junctions [25,31]. Over- 
expression of SHANK1 alters spine morphology, leading to 
the enlargement of spine heads [34]. On the other hand, 
Shank1 knockout mice have smaller spines than wild type, 
suggesting a role for SHANK1 in affecting the size of 
spines [37]. Depolarization elicits a significant increase in 
levels of SHANK1 in the contiguous network immediately 
below PSD and only a modest increase in SHANK2 [38]. 
Moreover, while the increase in SHANK1 is reversed in  
30 min, the increase in SHANK2 for the most part is main-
tained. These data indicate that SHANK1 is a dynamic ele-
ment within the spine, involved in activity-induced, transi-
ent structural changes, while SHANK2 appears to be a more 
stable element of the postsynaptic complex [38].  
Synaptic activity and excitatory stimuli elicit structural 
changes in spine morphology, a process called synaptic 
plasticity. These structural and molecular changes are be-
lieved to represent the basis for learning and memory. 
SHANK family members may play different roles in syn-
aptogenesis and synapse maturation. Their levels at the PSD 
are tightly regulated via Zn2+ ions in an isoform-specific 
way [39]. SHANK2 and SHANK3 are sensitive to Zn2+ ions 
via their SAM domains, whereas SHANK1 is Zn2+ insensi-
tive. Immature synapses exhibit a striking sensitivity to ex-
tracellular levels of Zn2+ ions that is not shared by mature 
synapses. This sensitivity is intimately linked to the differ-
ential expression and selective binding of Zn2+ ions to 
SHANK2 and SHANK3 but not SHANK1. SHANK family 
members are recruited consecutively to postsynaptic sites at 
different stages of development in primary hippocampal 
cultures. SHANK2 was the first to appear at PSDs, pre-
sented in all synapses while SHANK1 was detected in one 
third of all synapses at DIV (days in vitro) 7. During late 
development of synaptic contacts (DIV 21), 95% of all 
synapses were labeled with all three SHANK family mem-
bers [38]. Shank1 knockdown together with zinc depletion 
also reduced the number of “mushroom/stubby” synapses 
and leads to a shift towards smaller spine size [39].  
Tissue-specific methylation is one of the mechanisms for 
regulation of gene expression. DNA methylation status of 
human SHANK genes was analyzed in lymphocytes, brain 
cortex, cerebellum and heart. Seven CpG islands of 
SHANK1 and SHANK2 genes and five of SHANK3 were 
identified and analyzed for DNA methylation [40]. The 
majority of the CpG islands in SHANK1 and SHANK2 show 
extensive variability in methylation without apparent tis-
sue-specificity. SHANK3, on the other hand, undergoes tis-
sue-specific methylation at most of its CpG islands and 
highly methylated in tissues where its expression is low or 
absent, suggesting that SHANK3 expression might be regu-
lated by epigenetic mechanisms such as DNA methylation. 
Promoter-associated CpG islands of all SHANK members 
were always completely unmethylated.  
2  Mouse models of Shank1 
Shank1 mutant mice with a deletion of exons 14 and 15 
were produced and characterized by Hung et al. [37] in 
2008. These two exons encode almost the entire PDZ do-
main, a highly conserved region of Shank1. Since Shank1 
mutant mice in the B6 background had high mortality and 
Shank1 mice in the 129Jae background strain had very low 
locomotion, two lines were crossed to obtain a mixed 
C57BL/6/129SvJae (B6/Jae) background. The molecular 
and behavioral phenotypes of Shank1 mutant mice were 
studied. Shank1/ mutant mice showed altered protein 
composition of the PSD. There was a significant reduction 
of GKAP (~30%) and Homer1b/c (~20%), two scaffold 
proteins that bind directly with SHANK, while no signifi-
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cant difference in the levels of NMDA, AMPA, PSD-95, 
GRIP, -PIX (PAK-interacting exchange factor-) and cor-
tactin. Consistent with the biochemical results, the density 
of GKAP puncta was significantly decreased in Shank1/ 
mutant mouse brain. The immunostaining pattern of Homer 
was more diffuse though there was no significant change in 
density of Homer puncta in Shank1/ knockout mouse brain. 
These data support the idea that SHANK1 is important for 
synaptic accumulation of GKAP and Homer. No gross ab-
normalities in the size or histological structure of the brain 
(including cortex, hippocampus, and cerebellum) were de-
tected. In CA1 pyramidal neurons of hippocampus, signifi-
cantly smaller spine size, reduced PSD thickness and a se-
lective loss of the largest PSDs were observed in Shank1/ 
knockout mice compared with wild type mice, suggesting 
that SHANK1 may be critical for the development and/or 
maintenance of the largest subset of PSDs and synapses in 
particular. Shank1/ mutant mice showed decreased basal 
synaptic transmission as a result of a reduction in the num-
ber of functional synapses. The ratio of AMPAR and 
NMDAR EPSCs (excitatory postsynaptic currents) 
(AMPA/NMDA ratio) was not significantly different be-
tween wild type mice and Shank1/ mutant mice, suggest-
ing that the Shank1 deficiency does not affect the proportion 
of synaptic AMPA and NMDA receptors.  
The behavior of adult Shank1/ mutant mice was inves-
tigated in a variety of assays [37]. Shank1/ mutant mice 
were significantly less active in a novel open-field envi-
ronment than the wild-type littermate control mice, as 
measured by horizontal activity, total distance traveled and 
movement time. Shank1/ mutant mice showed increased 
anxiety-like behavior in open-field testing and the light/dark 
transition test. Shank1/ homozygous mice were poor 
breeders, did not nurture their pups, and their litters gener-
ally died before weaning. Shank1/ mutant mice have en-
hanced spatial learning but impaired long-term retention of 
this memory in eight-arm radial maze task in which animals 
must learn and remember the position of baited arms be-
tween trials while rapidly establishing memory of previous-
ly visited arms within a trial. In such a task, the Shank1/ 
mutant mice showed a steeper learning curve and reached a 
better performance level with fewer reference memory er-
rors and fewer working memory errors than the wildtype 
control mice. Together, these data indicate that Shank1 de-
ficient mice learn faster and more effectively during repeti-
tive training in the eight-arm radial maze.  
Autism has three core diagnostic symptoms including 
social communication deficits, language development delay, 
and stereotyped or repetitive behaviors and interests. Sil-
verman et al. [41] developed multiple mouse behavioral 
assays to investigate autism-relevant phenotypes in Shank1 
mutant mice. Both females and males of all three genotypes 
(Shank1/, Shank1+/, and Shank1+/+) were tested in the 
study, while only Shank1/ mutant males were studied in 
the first report of Shank1/ knockout mice. Social behaviors 
were examined through three aspects: reciprocal social in-
teractions in juvenile mice, adult sociability using automat-
ed three-chambered task in adult mice, and social interest in 
the olfactory habituation/dishabituation task. No genotype 
differences were observed for six parameters, i.e., nose-to- 
nose sniff, anogenital sniff, body sniff, push-crawl, push- 
past, and follow events, when characterizing active social 
interactions in juvenile Shank1 mice. All of Shank1 geno-
types (−/−, +/−, and +/+) failed to demonstrate significant 
sociability, which could not be attributed to their back-
ground strain since the hybrid B6/Jae mice showed normal 
sociability. Three potential explanations for the lack of so-
ciability in the Shank1 line were proposed by the authors. 
First, altered behavior of the Shank1+/ mutant mother mice 
could affect performance on behavioral tasks via epigenetic 
modulation. Second, home cage interactions among litter-
mate pups may affect later social performance. Third, ge-
netic drift across generations could have introduced varia-
tions in the mixture of genes from the two original back-
ground strains across individual subject mice. Stereotyped 
and repetitive behaviors were measured by self-grooming in 
Shank1 mutant mice. Though all Shank1 genotypes mice 
exhibited high levels of self-grooming, no significant dif-
ferences in self-grooming scores were detected across  
genotypes.  
Anxiety-like behavior was assessed using the light/dark 
test and the elevated plus-maze task [41]. Shank1/ mutant 
mice displayed significantly fewer transitions between the 
light and dark compartment as compared with Shank1+/+ 
and Shank1+/ heterozygotes, consistent with previous find-
ings. However, other parameters of the light/dark task and 
the elevated plus-maze task did not show difference across 
genotypes. The authors concluded that these results indicate 
a mild anxiety-like behavior attributable to the Shank1  
mutation.  
The major phenotypes of Shank1 mutant mice were mo-
tor impairments evaluated using three tasks, open field, 
rotarod, and wire hang [41]. Shank1 null mice displayed 
less total distance and spent less time in the center of the 
arena as compared to Shank1+/+ littermates in a novel open 
field. Shank1/ null mutant mice fell from the accelerating 
rotarod faster and from the inverted wire mouse cage lid 
faster than Shank1+/+ and Shank1+/ heterozygous littermate 
mice. Overall, Shank1/ mutant mice showed reduced ex-
ploratory locomotion and reduced motor coordination, bal-
ance and neuromuscular strength.  
Social communication of Shank1 mutant mice was fur-
ther evaluated using assays for ultrasonic vocalizations 
(USV) and scent marking in an open field, which are be-
lieved to be two major modes of mouse communication [42]. 
Deficits in several elements of social communication and 
early developmental milestones were detected in Shank1 
null mutant mice. Mouse pups emit USV when isolated 
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from their mother and littermates to elicit maternal search 
and retrieval behavior [43–46]. In adult mice, high USV 
levels are detected in males when courting and copulating 
with females. Several genetic mouse models of autism were 
reported to display reduced levels of pup USV, unusual 
calling patterns, or reduced levels of male USV production 
in response to females or female urine [47–51]. As pups, 
Shank1/ mutant mice emitted fewer USV and spent less 
time calling than Shank1+/+ littermate control mice when 
isolated from mother and littermates [42]. Calls emitted by 
Shank1/ mutant mouse pups were shorter, higher in peak 
frequency, but less frequency modulated than the ones 
emitted by Shank1+/+ control pups. These altered parameters 
of calls emitted by Shank/ mutant pups may decrease their 
signal value and elicit less maternal care-giving responses. 
As adults, Shank1+/+ wildtype males changed their calling 
pattern dependent on their previous exposure to a female, 
but Shank1/ mutant males were unaffected by prior female 
experience though both Shank1+/+ and Shank1/ male mice 
emitted a similar amount of USV when exposed to female 
urine. The lack of experience-induced changes in USV 
production may represent an inability to modulate social 
behaviors in response to experiences with social cues. In 
addition to USV, adult male mice display scent marking 
behavior, depositing urinary pheromone traces in close 
proximity to the location of female urine. Shank1/ mutant 
mice deposited fewer urine traces in proximity to the female 
urine spot than Shank1+/+ littermate control mice. Reduced 
levels of locomotor behavior were observed in Shank/ 
mutant mice, replicating the previous studies. The surface 
righting reflex was delayed in Shank1/ mutant as com-
pared to Shank1+/+ mice. Appearance of some physical de-
velopmental milestones, i.e. pinnae detachment and incisor 
eruption were delayed in Shank1/ mutant pups [42]. 
3  SHANK1 mutations are associated with ASD 
As compared with numerous reports of SHANK2 and 
SHANK3 mutations in ASD, there is so far only one report 
about the involvement of SHANK1 in ASD [22]. Copy- 
number variations (CNVs) screening was performed in a 
cohort of 1,158 unrelated Canadian individuals (898 males 
and 260 females) and 456 unrelated European individuals 
(362 males and 94 females) and sequence-level mutations of 
SHANK1 were tested in 509 unrelated ASD (384 males and 
125 females) and 340 intellectual disability (ID, 191 males 
and 149 females) individuals by Sato et al. [22]. They ini-
tially identified a hemizygous microdeletion of 63.8 kb 
which eliminated exons 1–20 of SHANK1 and the neigh-
boring CLEC11A gene in a four-generation family. Four 
male carriers were diagnosed with Asperger disorder or 
broader autism phenotype (BAP) whereas two female carri-
ers exhibited anxiety and shyness but would not be consid-
ered to have ASD or BAP. Another unrelated male case 
with the diagnosis of high-function autism was identified to 
have a de novo 63.4 kb hemizygous deletion which elimi-
nated the last three exons of SHANK1 and the entire cen-
tromeric synaptotagmin-3 (SYT3) gene. No equivalent dele-
tion was observed in 15,122 control individuals. The fre- 
quency of deletions at the SHANK1 locus is significantly 
higher in ASD cases than in controls. Remarkably, by 
whole-exome sequencing in two male individuals carrying 
the deletion of SHANK1 in the multigenerational family, a 
nonsense mutation (Tyr313*) in the PCDHGA11 gene, a 
member of the protocadherin gamma gene cluster thought to 
have an important role in establishing connections in the 
brain, was identified. The mutation was found to segregate 
precisely with the SHANK1 deletion. It is possible that the 
Tyr313* mutation in PCDHGA11 works in concert with the 
SHANK1 deletion to modify (positively or negatively) the 
extent of the phenotype or that they are just randomly 
cosegregating. 
The segregation of ASD in only male SHANK1-deletion 
carriers, but not female carriers, indicates gender-influenced 
autosomal penetrance differences at the SHANK1 locus in 
ASD. SHANK1 deletions are associated with ASD with 
higher functioning in males. The female carriers do not 
show evidence of ASD or BAP but have suffered from anx-
iety, which is considered to be a common comorbid condi-
tion but not a related phenotype to ASD. These results may 
help to explain the male gender bias in autism. Females 
need to carry more genetic liability than males in order to 
develop ASD. Consistent with these findings in humans, 
Shank1 null mice exhibit increased anxiety-related behavior 
and deficits in several elements of social communication 
and developmental milestones. 
By sequencing of all exons and splice sites of the 
SHANK1 gene in 509 unrelated ASD and 340 ID individu-
als, 26 rare missense variants were identified in 23 ASD and 
7 ID cases, which were not found in dbSNP (single nucleo-
tide polymorphism) build 130 or in 285 control individuals [22]. 
Only two missense variants were predicted to be deleterious 
since they alter highly conserved residues within the PDZ 
domain and ANK (ankyrin) domain. Although they oc-
curred in males with ASD, both variants were inherited with 
fathers with no symptoms of ASD.  
Given that important roles of SHANK family in synaptic 
function and the detection of SHANK2 and SHANK3 muta-
tions in ID and schizophrenia, it is reasonable to expect that 
SHANK1 mutations may contribute to other psychiatric dis-
orders. Lennertz et al. [52] genotyped 5 common SNPs in 
SHANK1, SHANK2 and SHANK3 and found one SNP 
rs3810280 in promoter region of SHANK1 was associated 
with working memory in schizophrenia cases. This associa-
tion was replicated in another cohort of 77 subjects with 
high risk of psychosis. Although the sample size was small, 
the association of SNPs of SHANK1 with schizophrenia 
indicates the involvement of SHANK1 in the pathogenesis 
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of neurodevelopmental disorders. 
4  Perspectives 
Although all SHANK family members have similar struc-
ture, the interaction proteins for each SHANK and related 
functions could be different. For example, SHANK2 and 
SHANK3 utilize their SAM domain for oligomerization and 
synaptic localization, while the PDZ domain of SHANK1 is 
critical for its postsynaptic localization. The different tem-
poral and spatial distribution of SHANK1 indicates its 
non-redundant function with other two SHANK members. 
The protein partners of SHANK1 and their specific func-
tions at excitatory synapses need to be illuminated.  
The male carriers of SHANK1 deletions were diagnosed 
with high-function autism. However, Shank1/ mutant mice 
did not show robust social deficits. Mice lacking Shank1 
display smaller spine size, reduced PSD thickness and 
weaker basal synaptic transmission. On behavioral level,  
Shank1/  mutant mice showed increased anxiety, en- 
hanced spatial learning, motor impairments, and altered 
social communication (reduced levels of ultrasonic vocali-
zations and scent marking behavior). One interpretation 
could be that the absence of Shank1 in mice may affect 
cognitive abilities including motor and spatial learning, in-
stead of direct effect on sociability. Double knockout mice 
of Shanks, i.e. Shank1 and Shank2 double knockout mice, 
will be interesting model to investigate the expression pat-
tern of synaptic proteins and behavioral phenotypes. 
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